These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1264387

  • 1. [Effects of salbutamol in bronchial asthma and in chronic obstructive bronchopathy].
    Guideri A.
    Minerva Med; 1976 Apr 07; 67(17):1115-9. PubMed ID: 1264387
    [No Abstract] [Full Text] [Related]

  • 2. [Our experience in the treatment of bronchial asthma and asthmatic bronchitis with salbutamol].
    Valenti S, Mirabelli S, Canonica GW, Brusasco V.
    Minerva Med; 1976 Mar 31; 67(16):1084-94. PubMed ID: 1264385
    [No Abstract] [Full Text] [Related]

  • 3. [Ventilatory and cardiocirculatory effects of salbutamol].
    Dotti A, Grasso Caprioli G, Quadri A, Rovetta A, Spedini C.
    Minerva Med; 1976 Apr 07; 67(17):1141-6. PubMed ID: 1264391
    [No Abstract] [Full Text] [Related]

  • 4. [Bronchodilator action and side effects of salbutamol in patients with bronchospasm of the respiratory tract].
    Cesco G.
    Minerva Med; 1976 Apr 07; 67(17):1151-4. PubMed ID: 1264393
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
    Sorbini CA, Todisco T, Boschetti E.
    Minerva Med; 1976 Mar 31; 67(16):1079-83. PubMed ID: 1264384
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma.
    Cummiskey J, Keelan P, Gray P, Cox GA.
    Ir Med J; 1978 Mar 18; 71(4):123-6. PubMed ID: 344272
    [No Abstract] [Full Text] [Related]

  • 7. [Our experience with salbutamol in the treatment of bronchial asthma and chronic asthmatiform bronchitis].
    Serembe M.
    Minerva Med; 1976 Mar 31; 67(16):1023-4. PubMed ID: 1264375
    [No Abstract] [Full Text] [Related]

  • 8. [Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type].
    Melillo G, D'Amato G, Cocco G.
    Minerva Med; 1976 Mar 13; 67(15):964-8. PubMed ID: 1264368
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical and functional considerations on the use of salbutamol].
    Orlandi O, Banaudi C, Bruna S, Dolcetti A, Perino B.
    Minerva Med; 1976 Mar 31; 67(16):1055-7. PubMed ID: 1264380
    [No Abstract] [Full Text] [Related]

  • 10. [Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma].
    Baños Hidalgo P, Ramos Martos A, Cabrera Moreno R, Luque Leal J, Palacios Giner A.
    Rev Clin Esp; 1983 Nov 30; 171(4):265-8. PubMed ID: 6229844
    [No Abstract] [Full Text] [Related]

  • 11. Oral salbutamol in obstructive airway disease.
    Store SD, Kamat SR, Warrier NV, Sanghavi B, Kulkarni PS, Sheth UK.
    Indian J Chest Dis; 1974 Jul 30; 16(3):144-52. PubMed ID: 4607448
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical study of the use of salbutamol (ventolin Glaxo)].
    Tansini GC, Gandola L, Soccini F.
    Minerva Med; 1976 Apr 07; 67(17):1160-4. PubMed ID: 1264394
    [No Abstract] [Full Text] [Related]

  • 13. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
    Fiora L.
    Minerva Med; 1976 Apr 07; 67(17):1165-75. PubMed ID: 1264395
    [No Abstract] [Full Text] [Related]

  • 14. [The efficacy of theopek in bronchial asthma and chronic bronchitis].
    Korzh OB.
    Ter Arkh; 1990 Apr 07; 62(3):82-4. PubMed ID: 2368005
    [Abstract] [Full Text] [Related]

  • 15. [Salbutamol in the treatment of severe broncho-asthmatic attacks].
    Ruggerini R, Romitti M, Sprocato S, Bianco F.
    Minerva Anestesiol; 1977 Apr 07; 43(4):239-43. PubMed ID: 876464
    [No Abstract] [Full Text] [Related]

  • 16. [Over-8-hour salbutamol effect in obstructive respiratory tract diseases].
    Kersten W.
    Fortschr Med; 1974 Apr 18; 92(11):487-91. PubMed ID: 4822455
    [No Abstract] [Full Text] [Related]

  • 17. [Pulmonary function tests on the bronchospasmolytic effects of the beta-2-adrenergics: salbutamol, terbutaline and NAB 365 (double placebo experiment)].
    Nolte D, Ulmer WT, Krieger E.
    Arzneimittelforschung; 1974 Jun 18; 24(6):858-60. PubMed ID: 4152715
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of beta-adrenergic drugs on bronchial secretion].
    Blasi A, Olivieri D, Marzo C.
    Minerva Med; 1976 Mar 31; 67(16):1049-54. PubMed ID: 4755
    [No Abstract] [Full Text] [Related]

  • 19. [Orciprenaline: an "old" bronchodilator still valid. Comparative study of the bronchodilator effect of orciprenaline and salbutamol in patients with obstructive type respiratory dysfunctional syndrome].
    Petraglia A, De Cataldis G, Tarantino O, Materazzi F.
    Clin Ter; 1976 Dec 31; 79(6):555-62. PubMed ID: 1009760
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical study of the use of salbutamol in patients with bronchial asthma].
    Bariffi F, Marsico SA, Brancaccio L.
    Minerva Med; 1976 Mar 13; 67(15):983-7. PubMed ID: 1264370
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.